I would think that, with his considerable success in commercialising NAN'S products, Ron W will know what to do. In fact, commercial partnershipping is slated to begin in earnest later this year. My understanding is that established distributional channels, rather than direct selling, will be the business model used.
Ann: Stage 2 of Clinical Trial Activated, page-19
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.10 |
Change
-0.120(5.41%) |
Mkt cap ! $179.3M | |||
| Open | High | Low | Value | Volume |
| $2.15 | $2.17 | $2.07 | $25.34K | 11.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 318 | $2.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.22 | 1374 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |